Myrcludex B

Overview

Myrcludex B is a drug candidate for the treatment of hepatitis B and D. It is under a phase II clinical trial. Myrcludex B acts by inhibiting the sodium taurocholate cotransporting polypeptide. Sequence: Myristoyl-GTNLSVPNPLGFFPDHQLDPAFGANSNNPDWDFNPNKDHWPEANKVG Source summary: Myrcludex B is a pioneering peptide compound used in advanced research on viral entry mechanisms and liver disease studies. Inquire now for cutting-edge research solutions.

Application

Products > Drug Discovery > Inhibitor > Other Inhibitors | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B0084-112349
• CAS No.: 2012558-47-1
• Molecular Formula: C248H355N65O72
• Molecular Weight: 5398.95
• Purity: ≥98%
• Storage: Store at -20°C

Source

Original product source